4.4 Article

Effects of glucose, lactate and basic FGF as limiting factors on the expansion of human induced pluripotent stem cells

Journal

JOURNAL OF BIOSCIENCE AND BIOENGINEERING
Volume 125, Issue 1, Pages 111-115

Publisher

SOC BIOSCIENCE BIOENGINEERING JAPAN
DOI: 10.1016/j.jbiosc.2017.08.004

Keywords

Induced pluripotent stem cells; Glucose; Lactate; Basic fibroblast growth factor; Heparan sulfate; Cell expansion; Mass production; Regenerative medicine

Funding

  1. Japan Society for the Promotion of Science (JSPS) [25-9088]
  2. Japan Agency for Medical Research and Development (AMED)

Ask authors/readers for more resources

Pluripotent stem cells (PSCs) are one of the promising cell sources for tissue engineering and drug screening. However, mass production of induced pluripotent stem cells (iPSCs) is still developing. Especially, a huge amount of culture medium usage causes expensive cost in the mass production process. In this report, we reduced culture medium usage by extending interval of changing culture medium. In parallel, we also increased glucose concentration and supplied heparan sulfate to avoid depletion of glucose and bFGF, respectively. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analyses showed that reducing medium change frequency increased differentiation marker expressions but high glucose concentration downregulated these expressions. In contrast, heparan sulfate did not prevent differentiation marker expressions. According to analyses of growth rate, cell growth with extended medium change interval was decreased in later stage of log growth phase despite the existence of high glucose concentration and heparan sulfate. This result and culturing iPSCs with lactate showed that the accumulation of excreted lactate decreased the growth rate regardless of pH control. Conclusively, these experiments show that adding glucose and removing lactate are important to expand iPSCs with reduced culture medium usage. This knowledge should be useful to design economical iPSC mass production and differentiation system. (C) 2017, The Society for Biotechnology, Japan. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available